Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.
Miller FW, Cooper RG, Vencovský J, Rider LG, Danko K, Wedderburn LR, Lundberg IE, Pachman LM, Reed AM, Ytterberg SR, Padyukov L, Selva-O'Callaghan A, Radstake TR, Isenberg DA, Chinoy H, Ollier WE, O'Hanlon TP, Peng B, Lee A, Lamb JA, Chen W, Amos CI, Gregersen PK; Myositis Genetics Consortium. Miller FW, et al. Among authors: vencovsky j. Arthritis Rheum. 2013 Dec;65(12):3239-47. doi: 10.1002/art.38137. Arthritis Rheum. 2013. PMID: 23983088 Free PMC article.
Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
Miller FW, Rider LG, Chung YL, Cooper R, Danko K, Farewell V, Lundberg I, Morrison C, Oakley L, Oakley I, Pilkington C, Vencovsky J, Vincent K, Scott DL, Isenberg DA; International Myositis Outcome Assessment Collaborative Study Group. Miller FW, et al. Among authors: vencovsky j. Rheumatology (Oxford). 2001 Nov;40(11):1262-73. doi: 10.1093/rheumatology/40.11.1262. Rheumatology (Oxford). 2001. PMID: 11709610 Review.
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease.
Isenberg DA, Allen E, Farewell V, Ehrenstein MR, Hanna MG, Lundberg IE, Oddis C, Pilkington C, Plotz P, Scott D, Vencovsky J, Cooper R, Rider L, Miller F; International Myositis and Clinical Studies Group (IMACS). Isenberg DA, et al. Among authors: vencovsky j. Rheumatology (Oxford). 2004 Jan;43(1):49-54. doi: 10.1093/rheumatology/keg427. Epub 2003 Jul 16. Rheumatology (Oxford). 2004. PMID: 12867580 Review.
Treatment-resistant inflammatory myopathy.
Mann HF, Vencovsky J, Lundberg IE. Mann HF, et al. Among authors: vencovsky j. Best Pract Res Clin Rheumatol. 2010 Jun;24(3):427-40. doi: 10.1016/j.berh.2009.12.008. Best Pract Res Clin Rheumatol. 2010. PMID: 20534375 Review.
Interrater reliability and aspects of validity of the myositis damage index.
Sultan SM, Allen E, Cooper RG, Agarwal S, Kiely P, Oddis CV, Vencovsky J, Lundberg IE, Dastmalchi M, Hanna MG, Isenberg DA. Sultan SM, et al. Among authors: vencovsky j. Ann Rheum Dis. 2011 Jul;70(7):1272-6. doi: 10.1136/ard.2010.142117. Ann Rheum Dis. 2011. PMID: 21622773
Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study.
Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, Kapitány A, Gyetvai A, Ekholm L, Novota P, Remakova M, Charles P, McHugh NJ, Padyukov L, Alfredsson L, Vencovsky J, Lundberg IE, Danko K, Ollier WE, Cooper RG. Chinoy H, et al. Among authors: vencovsky j. Ann Rheum Dis. 2012 Jun;71(6):961-5. doi: 10.1136/annrheumdis-2011-200182. Epub 2011 Dec 20. Ann Rheum Dis. 2012. PMID: 22186711 Free PMC article.
Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature.
Labirua-Iturburu A, Selva-O'Callaghan A, Vincze M, Dankó K, Vencovsky J, Fisher B, Charles P, Dastmalchi M, Lundberg IE. Labirua-Iturburu A, et al. Among authors: vencovsky j. Medicine (Baltimore). 2012 Jul;91(4):206-211. doi: 10.1097/MD.0b013e318260977c. Medicine (Baltimore). 2012. PMID: 22732951 Free article. Review.
Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: a randomized, placebo-phase trial.
Oddis CV, Reed AM, Aggarwal R, Rider LG, Ascherman DP, Levesque MC, Barohn RJ, Feldman BM, Harris-Love MO, Koontz DC, Fertig N, Kelley SS, Pryber SL, Miller FW, Rockette HE; RIM Study Group. Oddis CV, et al. Arthritis Rheum. 2013 Feb;65(2):314-24. doi: 10.1002/art.37754. Arthritis Rheum. 2013. PMID: 23124935 Free PMC article. Clinical Trial.
264 results